Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NiproTSE:8086 +0.39%70 Forward Dividend Yield % is 2.06% as of Jul. 14, 2026. GuruFocus rates TSE:8086 with a GF Score™ of 70/100 and a GF Value™ of 円1,457.04 (Fairly Valued). The stock has 6 warning signs investors should review. Among 313 Medical Devices & Instruments companies, Nipro ranks better than 50.16% on this metric.
As of today (2026-07-14), the Forward Annual Dividend Yield of Nipro is 2.06%.
As of today (2026-07-14), the Trailing Annual Dividend Yield of Nipro is 1.87%.
TSE:8086's Forward Dividend Yield % is ranked better than 50.16% of 313
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs TSE:8086: 2.06
During the past 12 months, Nipro's average Dividends Per Share Growth Rate was 16.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 9.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 0.70% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -1.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Nipro was 17.70% per year. The lowest was -22.50% per year. And the median was -1.20% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
TSE:8086 vs ISRG, BDX, MDLN: Forward Dividend Yield % Comparison
For the Medical Instruments & Supplies subindustry, Nipro's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nipro Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Nipro's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Nipro Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 19.000000
2026-03-30
2026-03-31
2026-06-10
Cash Dividend
semi-annually
JPY:JPY 1.000000
JPY 10.000000
2025-09-29
2025-09-30
2025-12-10
Cash Dividend
semi-annually
JPY:JPY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Nipro's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
38
/
1552.50
=
2.45 %
Current Share Price is 円1552.50. Nipro's Dividends per Share for the forward twelve months is calculated as 円19 * 2 = 円38.
Nipro's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
29
/
1552.50
=
1.87 %
Current Share Price is 円1552.50. Nipro's Dividends per Share for the trailing twelve months (TTM) ended in Today is 円29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 2.06% mean?
Nipro (TSE:8086) has a Forward Dividend Yield % of 2.06% as of Jul. 14, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Nipro and its competitors. According to the industry distribution chart, Nipro ranks #156 out of 313 companies in the Medical Devices & Instruments industry, placing it in the top 49.8%.
Is Nipro's Forward Dividend Yield % too high?
Nipro's current Forward Dividend Yield % is 2.06%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.07. Nipro's value of 2.06% is 0.5% below this industry median. Based on the distribution chart, Nipro ranks #156 out of 313 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nipro has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nipro's Forward Dividend Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nipro ranks #156 out of 313 companies for Forward Dividend Yield %. This puts Nipro in the upper half of its industry. The industry median Forward Dividend Yield % is 2.07. Nipro's value of 2.06% is 0.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.07, based on 313 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nipro's current Forward Dividend Yield % of 2.06% is 0.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Nipro and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nipro's current Forward Dividend Yield % is 2.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Based on GuruFocus' analysis, Nipro (TSE:8086) is currently considered Fairly Valued. The stock's GF Value™ is 円1,457.04, compared to a current price of 円1,552.50 — trading 6.6% above its estimated fair value. The current Forward Dividend Yield % is 2.06% and 0.5% below the Medical Devices & Instruments industry median of 2.07. Nipro's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Nipro (TSE:8086), the current Forward Dividend Yield % is 2.06% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nipro (TSE:8086) Overvalued in 2026?
Based on GuruFocus' analysis, Nipro stock appears to be overvalued.
The current stock price of 円1,552.50 is trading 6.6% above its estimated GF Value™ of 円1,457.04.
GuruFocus considers Nipro to be Fairly Valued.
Key valuation signals for TSE:8086:
Forward Dividend Yield %: 2.06%
GF Value™: 円1,457.04 vs. price of 円1,552.50 (6.6% above fair value)
Industry Position: 0.5% below the Medical Devices & Instruments median (#156 of 313)
No single metric tells the full story. See the TSE:8086 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
70GF Score
Get the complete analysis for TSE:8086
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:8086 has been successfully added to your 
